Shares of Trupanion Inc (NYSE:TRUP) have been assigned a consensus rating of “Buy” from the eight analysts that are currently covering the firm. Two equities research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $15.57.

A number of equities research analysts have recently weighed in on TRUP shares. Zacks Investment Research lowered shares of Trupanion from a “buy” rating to a “hold” rating in a report on Wednesday, July 27th. Stifel Nicolaus boosted their price objective on shares of Trupanion from $17.00 to $20.00 and gave the company a “buy” rating in a report on Wednesday, August 3rd. RBC Capital Markets reissued an “outperform” rating and set a $18.00 price objective (up from $14.00) on shares of Trupanion in a report on Wednesday, August 3rd. Finally, Canaccord Genuity reissued a “buy” rating and set a $19.00 price objective on shares of Trupanion in a report on Thursday, August 4th.

Shares of Trupanion (NYSE:TRUP) opened at 16.65 on Thursday. The company’s market capitalization is $487.06 million. Trupanion has a 12-month low of $7.50 and a 12-month high of $17.68. The firm’s 50-day moving average price is $16.09 and its 200-day moving average price is $15.10.

Trupanion (NYSE:TRUP) last announced its quarterly earnings data on Tuesday, November 1st. The company reported ($0.06) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.06). The company had revenue of $48.40 million for the quarter, compared to analysts’ expectations of $48.17 million. Trupanion’s quarterly revenue was up 27.7% compared to the same quarter last year. During the same period last year, the firm earned ($0.17) earnings per share. On average, analysts expect that Trupanion will post ($0.23) EPS for the current fiscal year.

In other Trupanion news, Director Howard E. Rubin sold 4,369 shares of the company’s stock in a transaction dated Monday, August 22nd. The shares were sold at an average price of $14.94, for a total value of $65,272.86. Following the completion of the transaction, the director now owns 168,055 shares in the company, valued at $2,510,741.70. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Howard E. Rubin sold 17,556 shares of the company’s stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $14.93, for a total transaction of $262,111.08. Following the completion of the transaction, the director now owns 162,399 shares of the company’s stock, valued at approximately $2,424,617.07. The disclosure for this sale can be found here.

Several hedge funds and other institutional investors have recently modified their holdings of the company. State Street Corp increased its position in shares of Trupanion by 50.5% in the second quarter. State Street Corp now owns 199,861 shares of the company’s stock worth $2,650,000 after buying an additional 67,026 shares during the period. Alliancebernstein L.P. purchased a new position in shares of Trupanion during the second quarter worth $168,000. BlackRock Institutional Trust Company N.A. increased its position in shares of Trupanion by 15.9% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 149,097 shares of the company’s stock worth $1,976,000 after buying an additional 20,461 shares during the period. BlackRock Investment Management LLC increased its position in shares of Trupanion by 2.7% in the second quarter. BlackRock Investment Management LLC now owns 59,881 shares of the company’s stock worth $793,000 after buying an additional 1,599 shares during the period. Finally, Vanguard Group Inc. increased its position in shares of Trupanion by 8.1% in the second quarter. Vanguard Group Inc. now owns 545,545 shares of the company’s stock worth $7,228,000 after buying an additional 41,036 shares during the period.

Trupanion Company Profile

Trupanion, Inc provides a medical insurance plan for cats and dogs across the United States, Canada and Puerto Rico. The Company operates through two segments: subscription business and other business. The subscription business segment includes monthly subscriptions related to the Company’s medical plan, which are marketed directly to consumers.

5 Day Chart for NYSE:TRUP

Receive News & Stock Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related stocks with our FREE daily email newsletter.